Xeomics

🗓 Founded 2024👥 10 employees💰 Last funded Sep 2026
Biotechnology Research🌐 xeomics.com
Website LinkedIn
We offer real-world data, innovative solutions, and programs that enable personal medicine and population-wide genomics. Xeomics collaborates with federal institutions, global organizations, and leading health systems in establishing community-wide and population-wide initiatives that enable precision medicine at scale. In support of these programs, Xeomics offers the Xeomics Precision Medicine Suite (XMPS), a best-in-class bioinformatics and precision medicine software solution that provides valuable healthcare insights and benefits to doctors and patients.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Xeomics?
Xeomics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Xeomics last raise funding?
The most recent investment in Xeomics recorded on gritt.io was in September 2026.
When was Xeomics founded?
Xeomics was founded in 2024.
What industry is Xeomics in?
Xeomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.